News ArticleIndegene Limited Approves Q2 and H1 FY 2026 Unaudited Financial Results and Employee Stock Allotments
Board meeting on October 29, 2026, also notes key resignations and policy amendments; trading window reopens November 2, 2026
Indegene Limited announced its unaudited standalone and consolidated financial results for the second quarter and half year ended September 30, 2026, approved by the Board on October 29, 2026. The Board also approved allotment under RSU Scheme 2020 and ESOP Scheme 2020, accepted resignations of a Non-Executive Director and Company Secretary, and amended its Prevention of Sexual Harassment Policy.
Indegene Limited
General / Other
Indegene Limited announced unaudited standalone and consolidated financial results for the quarter and six months ended September 30, 2026. The Board approved stock allotments under its 2020 RSU and ESOP schemes and accepted key personnel resignations during the October 29, 2026 meeting.
The Board approved the unaudited standalone and consolidated financial statements along with a limited review report, which carries an unmodified opinion from the auditors Deloitte Haskins & Sells.
Allotments under the Restricted Stock Units (RSU) Scheme 2020 and Employee Stock Option Plan (ESOP) Scheme 2020 were approved to eligible employees.
The Board accepted the resignation of Mr. Mark Francis Dzialga from his position as Non-Executive Non-Independent Director, effective close of business on October 29, 2026, and acknowledged his contributions during his tenure.
The Nomination and Remuneration Committee and the Investment Committee were reconstituted following Mr. Dzialga's cessation of membership.
Ms. Srishti Ramesh Kaushik resigned as Company Secretary, Compliance Officer, and Key Managerial Personnel, effective end of business on December 2, 2026. The Board appreciated her service to the company during her tenure and announced her forthcoming relief from duties on that date, with detailed particulars provided as per SEBI regulations.
Highlights
- Unaudited financial results for Q2 and H1 ended September 30, 2026, approved with unmodified audit opinion.
- Allotment of shares under RSU and ESOP Schemes 2020 approved.
- Resignation of Mr. Mark Francis Dzialga as Non-Executive Director effective October 29, 2026.
- Resignation of Ms. Srishti Ramesh Kaushik as Company Secretary effective December 2, 2026.
- Prevention of Sexual Harassment Policy amended.
- Trading window reopened for Designated Persons from November 2, 2026.
Key Data Snapshot
What happened
- Indegene Limited approved its unaudited standalone and consolidated financial results for the second quarter and six months ended September 30, 2026.
- The Board approved share allotments under the RSU Scheme 2020 and ESOP Scheme 2020.
- The company accepted the resignation of Mr. Mark Francis Dzialga as Non-Executive Non-Independent Director effective October 29, 2026.
- Resignation of Ms. Srishti Ramesh Kaushik as Company Secretary, Compliance Officer, and Key Managerial Personnel, effective December 2, 2026, was accepted.
- An amendment to the company's Prevention of Sexual Harassment Policy was approved.
- The trading window for designated persons will reopen on November 2, 2026.
Key details
- The unaudited consolidated financial results include operations of Indegene Limited and its subsidiaries worldwide.
- The independent auditor, Deloitte Haskins & Sells, issued a limited review report with an unmodified opinion dated October 29, 2026.
- Details of share allotments under the RSU and ESOP schemes were disclosed as per SEBI regulatory requirements.
- The Nomination and Remuneration Committee and Investment Committee were reconstituted following director resignation.
- The company expressed appreciation for the resigning Non-Executive Director and Company Secretary for their services.
Regulatory and governance context
- Share allotments comply with SEBI Listing Obligations and Disclosure Requirements Regulations, 2015 and SEBI master circular on disclosures.
- Resignation and committee reconstitution details provided as per Regulation 30 of SEBI Listing Regulations.
- Prevention of Sexual Harassment Policy amended to meet updated standards or requirements.
- Trading window reopening notification aligns with SEBI Prohibition of Insider Trading Regulations, 2015.
Highlights
- Unaudited financial results for Q2 and H1 ended September 30, 2026, approved with unmodified audit opinion.
- Allotment of shares under RSU and ESOP Schemes 2020 approved.
- Resignation of Mr. Mark Francis Dzialga as Non-Executive Director effective October 29, 2026.
- Resignation of Ms. Srishti Ramesh Kaushik as Company Secretary effective December 2, 2026.
- Prevention of Sexual Harassment Policy amended.
- Trading window reopened for Designated Persons from November 2, 2026.
Disclosures
- SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
- SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026
- SEBI (Prohibition of Insider Trading) Regulations, 2015
More News on General / Other
View allLatest corporate announcements and market updates in General / Other.
Deepak Nitrite Reports Highest-Ever Quarterly Revenue of ₹3,091 Crore and 187% EBITDA Growth in Q2 FY27
Deepak Nitrite Limited announced record financial results for the second quarter and first half of FY27, with consolidated revenue reaching ₹3,091 crore in Q2 representing a 61% year-on-year increase, while EBITDA soared 187% to ₹643 crore. The phenolics segment notably achieved a record EBIT of ₹933 crore in the first half of FY27, surpassing its prior full-year high.
Read Full Story
Indegene Limited Posts 39.5% Year-on-Year Revenue Growth in Q2 FY27 with Stable Margins
Indegene Limited announced strong financial performance for the second quarter ended September 30, 2026, reporting revenue of ₹11,223 million, up 39.5% year-on-year, with stable EBITDA margin at 16.7% despite wage increases. The company's profit after tax reached ₹1,123 million, supported by an expanded client base and improved revenue per employee.
Read Full Story
CAMS Posts 14.4% PAT Rise to ₹131.49 Crore and Declares Rs. 3.25 Interim Dividend for Q2 FY27
Computer Age Management Services Limited (CAMS) reported a 14.4% year-on-year increase in consolidated profit after tax to ₹131.49 crore for the quarter ended September 30, 2026, driven by a 10% rise in operating revenue to ₹414.47 crore. The company recommends an interim dividend of Rs. 3.25 per share, supported by robust growth in both its mutual fund and non-mutual fund businesses.
Read Full Story
